Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

od Roy, Lynn, Cowden Dahl, Karen D.
izdano v Cancers (Basel) (2018)

MiR-24 Is Required for Hematopoietic Differentiation of Mouse Embryonic Stem Cells

od Roy, Lynn, Bikorimana, Emmanuel, Lapid, Danica, Choi, Hyewon, Nguyen, Tan, Dahl, Richard
izdano v PLoS Genet (2015)

Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Exp...

od Maculaitis, Martine C, Liu, Xianchen, Will, Oliver, Hanson, Madelyn, McRoy, Lynn, Berk, Alexandra, Crastnopol, Melissa
izdano v Patient Prefer Adherence (2020)

ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature

od Roy, Lynn, Samyesudhas, Serene J., Carrasco, Martin, Li, Jun, Joseph, Stancy, Dahl, Richard, Dahl, Karen D. Cowden
izdano v Oncotarget (2014)

CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche

od Roy, Lynn, Bobbs, Alexander, Sattler, Rachel, Kurkewich, Jeffrey L, Dausinas, Paige B, Nallathamby, Prakash, Cowden Dahl, Karen D
izdano v Cancer Growth Metastasis (2018)

Convergence of 3′,5′-Cyclic Adenosine 5′-Monophosphate/Protein Kinase A and Glycogen Synthase Kinase-3β/β-Catenin Signaling in Corpus Luteum Progesterone Synthesis

od Roy, Lynn, McDonald, Claudia A., Jiang, Chao, Maroni, Dulce, Zeleznik, Anthony J., Wyatt, Todd A., Hou, Xiaoying, Davis, John S.
Izdano 2009

A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application

od Richardson, David, Zhan, Lin, Mahtani, Reshma, McRoy, Lynn, Mitra, Debanjali, Reynolds, Maria, Odom, Dawn, Hollis, Kelly, Kaye, James A., Jones, Cheryl, Hargis, Jeffrey
izdano v Breast Cancer Res Treat (2021)

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice

od DeMichele, Angela, Cristofanilli, Massimo, Brufsky, Adam, Liu, Xianchen, Mardekian, Jack, McRoy, Lynn, Layman, Rachel M., Emir, Birol, Torres, Mylin A., Rugo, Hope S., Finn, Richard S.
izdano v Breast Cancer Res (2021)

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast...

od Finn, Richard S., Boer, Katalin, Bondarenko, Igor, Patel, Ravindranath, Pinter, Tamas, Schmidt, Marcus, Shparyk, Yaroslav V., Thummala, Anu, Voitko, Nataliia, Bananis, Eustratios, McRoy, Lynn, Wilner, Keith, Huang, Xin, Kim, Sindy, Slamon, Dennis J., Ettl, Johannes
izdano v Breast Cancer Res Treat (2020)

In vivo tumor growth of high-grade serous ovarian cancer cell lines

od Mitra, Anirban, Davis, David A., Tomar, Sunil, Roy, Lynn, Gurler, Hilal, Xie, Jia, Lantvit, Daniel D., Cardenas, Horacio, Fang, Fang, Liu, Yueying, Loughran, Elizabeth, Yang, Jing, Stack, M. Sharon, Emerson, Robert E, Cowden Dahl, Karen D., Barbolina, Maria, Nephew, Kenneth P., Matei, Daniela, Burdette, Joanna E.
izdano v Gynecol Oncol (2015)